Full partners

The NANOMED consortium gathers 4 European Schools of Pharmacy as full partners (Paris Descartes University, Pavia University, Patras University and Angers University) as well as various associated partners such as Universities, research institutions, professional associations and private companies.

NANOMED full partners

The core groups organizing this EMJMD bear the advantage of including within their Universities and/or Collaborating Higher Education Institutions numbers of experts from different areas related to Nanomedicine. These experts will share their knowledge as lecturers in the basic and advanced courses of the programme, but also as advisors for projects that may require input from other disciplines.

The four partner Universities are well equipped with Large-Scale facilities which are pivotal to organize top-level post-graduate courses on the characterization of Nanoparticles (diffraction light scattering and electrophoretic mobility, DSC, FTIR, XRD, HPLC and UPLC – UV detection, mass spectroscopy… -, Raman Spectroscopy, interfacial rheology, etc.), their visualization by microscopy (Confocal Scanning, TEM, AFM, FRAP and SEM Microscopy Units) and their biological evaluation, both in vitro on cell cultures (complement activation, cytotoxicity assay, oral transport model, etc.) and in vivo on appropriate animal models (housing facilities, live animal imaging platforms, etc..).

Paris (Coordinator) - Paris Descartes University

Paris Descartes University is the largest comprehensive University in France, and the only one gathering in the same institution Medicine, Pharmacy, Dentistry, Nursing and Maieutic faculties. It is also a founding member of the Sorbonne Paris Cité alliance, a public community of academic institutions gathering four multidisciplinary Universities – Sorbonne Nouvelle, Paris Descartes, Paris Diderot and Paris 13 – as well as four Higher Education and Research Institutions.

With 7000 foreign students, Paris Descartes has a strong attractiveness for students and faculties from all over the world due to its large range of high quality academic programmes in health, basic sciences, technology, human and social sciences, law, economics, management and psychology. Moreover, Paris Descartes University has an ambitious vision of internationalization and has already signed 130 bilateral agreements with more than 40 countries around the world, which includes 9 double degrees, at the Master or PhD level.

Within Paris Descartes University, the School of Pharmacy currently holds a Master’s degree dedicated to Pharmaceutical Sciences and gathering Professors (from Paris Descartes, Paris Sud, Dijon Universities), Hospital-based researchers (Parisian Hospitals and AGEPS – Agency for the production of drugs for Parisian hospitals-), and Industrials (SANOFI, GALDERMA, CAPSUGEL).

This programme is also supported locally by the research group dedicated to Chemical and Biological Techniques for Health (UTCBS, Head: Dr. D. Scherman). This research group gathers researchers from CNRS, INSERM as well as tenured Professors and Associate Professors displaying various backgrounds ranging from Chemistry, Physico-Chemistry and Analytical Chemistry to Molecular and Cellular Biology. It holds two University-labelled platforms (since 2014) dedicated to the physico-chemical characterization of drug delivery systems and small animal models imaging (MRI and optical). Altogether the facilities and the multidisciplinary expertise allow for the design and development of innovative drug delivery systems based on Nanomedicine concepts such as liposomes and spherulites for nucleic acids delivery, gas nanobubbles permeabilizing membranes using focalized ultrasounds, inorganic nanoparticles for live animal imaging, etc. Moreover Dr. Nathalie Mignet, head of one of UTCBS research teams is also the current President of the French Society of Nanomedicine (SF Nano), which organises each year scientific conferences dedicated to this research area.

Patras - The University of Patras

The University of Patras holds a very large School of Medicine (with a University Hospital -the largest in Western Greece-), a Polytechnic School including Departments of Chemical and Electrical Engineering and Computer Sciences, as well as a School of Natural Sciences including Departments of Material Sciences, Chemistry, Physics and Biology.

Within the University of Patras, the School of Pharmacy is currently offering a Master’s degree in Pharmaceutical Technology, in conjunction with the University’s aforementioned Institutions.

This programme is supported by the research activities of Pr. Sophia Antimisiaris’ laboratory focusing on nanoparticulate drug delivery systems (main focus on liposomes or hybrid [lipid/polymer] nanoparticles). The research projects are developed in collaboration with the Institute of Chemical Engineering and Sciences (FORTH/ICE, located in Patras). This Institute is part of the Foundation of Research and Technology Hellas (FORTH) [the largest Research Institute in Greece], which is an associated partner of the NANOMED EMJMD. The FORTH/ICE Institute is very well equipped with core facilities that could be used by the students during their experimental work and can also contribute to the technical training (particle sizing and characterization). Furthermore, this group has already organized four Intensive Programmes/Workshops as part of a post-graduate diploma and a former Marie Curie Program [Galenos network] on the topic of Liposome Technology / Nanomedicine for Drug Delivery and has participated as a core-group/Home Institution for a Marie Curie, early stage PhD Programme, on the same Subject (Euro PhD on Advanced Drug Delivery Systems).

Angers - The University of Angers

The University of Angers engages in active exchanges with all five continents, was among the first to develop strong links with Eastern Europe, and participates fully in European Union programmes. Furthermore, the School of Pharmacy of Angers has a strong programme of students and research exchange with the Schools of Pharmacy of Nottingham (UK) and Ho Chi Minh Ville (Vietnam). It is also the coordinator of the NanoFar and Nanofar + networks, the European joint doctorate programme in Nanomedicine.

Moreover, the School of Pharmacy offers since 2012 a Master’s degree in Nanomedicine in partnership with both the Micro and Nanomedicine biomimeTic (MINT) research unit  (managed by Pr. Jean-Pierre Benoit) and the Innovation Department of the ISTIA School of Engineering. The ‘Nanomédecines and R&D Pharmaceutique’ Master’s degree focuses on the innovation and the development of experimental medicines.

At the Health Department of the University of Angers, the MINT research unit (UMR INSERM U1066/CNRS 6021) is a translational team specializing in the design and evaluation of carriers (micro and nanoparticles) for therapeutic and imaging purposes, in oncology, immunology and infectiologyin oncology and neurodegenerative diseases. The MINT laboratory is the coordinator of the European Research project ‘Niche’ and partner of ‘FormamP’ and ‘Trans-Int’. The MINT laboratory is deeply involved in the development of Nanomedicine and organized in 2014 the 2nd International Conference on “Translational Nanomedicine”. The aim of this scientific meeting was to bring together scientists, medical staff, pharmaceutical industry and regulatory bodies, in order to present and discuss the main barriers for the market access of Nanomedicine.

Pavia - The University of Pavia

The University of Pavia gathers a Department of Drug Sciences, a Medical and Surgical School, a Department of Chemistry and a Department of Biology and Biotechnology, providing undergraduate education in the fields of Pharmacy, Biotechnologies, Molecular Biology and Bioengineering. It delivers numerous diplomas from License, to Master’s and PhD level, in particular the newly developed two-year Master Course in Nanomedicine for drug delivery.

The NANOMED curriculum is supported by the research activities of the Pharmaceutical Chemistry and Technology laboratories of the Department of Drug Sciences, engaged in the field of advanced nanotechnology- and nanobiotechnology-based formulations for parenteral, oral and local delivery of small molecules as well as biotech drugs and vaccines. The University of Pavia is collaborating with local hospitals (IRSSC Policlinico S.Matteo, IRCCS Salvatore Maugeri) hosting clinical research units. Moreover the Department holds close relationships with University Centers and spin-off active in nanoparticle research and involved in educational and research cooperation, notably for the practical training part of the Nanomed programme. In particular the Centre for Health Technology (CHT), currently involving eleven departments provides technological solutions for solving problems in human health, from bench to bedside, by fostering interdisciplinary research that integrates basic sciences, medicine, pharmaceutics and engineering, taking into account also legal and ethical issues. CHT is currently active, among others, in nanomedicine technology for diagnostics and therapy, including personalized medicine, and provides advanced diagnostic instrumentation and methods for the bio-characterization of nanomaterials. Several projects included in the CHT are currently funded by the EU, by NATO, by private Foundations and the Lombardia region. Two academic spin-offs named Polymerix and Noxamed are also active at the University of Pavia providing services on modern preparative methods of polymeric nanosystems and on nanotoxicology, respectively.

Finally the department of Drug Sciences has strong connections with CRS Italian chapter, Jointly they are organizing, within the frame of the annual meeting of the Association of Industrial Pharmacists, June 2017, a Mini-symposium on Recent development of Nanomedicines for drug delivery: achievements, opportunities and challenges, which will host esteemed speakers from the Nanomed project and deliver the Recipharm Award entitled “From Nanotechnologies to Nanomedicines”.

Back to Top